Click here to subscribe to our newsletter |
|
|
Articles |
|
|
|
|
Flexible production: meeting the growing demands of the biotechnology sector
The biotech company Bavarian Nordic relied on state-of-the-art technology and expertise from Syntegon Technology for its new isolator filling line for freeze dried and liquid vaccine serums.
|
|
| | | | |
| |
|
Creating your Secondary Packaging Strategy
Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial launch. Secondary packaging aspects are often less considered. Correlations with secondary packaging .. .
|
|
|
|
| | | |
|
|
Latest News & Press Releases |
|
|
|
|
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial's vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an effective immune response against Covid-19....
|
|
| | | | |
| |
|
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant as a potential treatment for COVID-19 in a Phase III study. Indianapolis-based Eli Lilly said the latest study will complement an ongoing study of the rheumatoid...
|
|
|
|
|
| |
|
|
|
Atyr Pharma Announces Dosing Of First Patient In Phase 2 Trial Of ATYR1923 In Covid-19 Patients
aTyr Pharma, Inc., announced that it has dosed the first patient in a Phase 2 study evaluating its lead therapeutic candidate, ATYR1923, in COVID-19 patients with severe respiratory complications.
|
|
|
| |
| |
|
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent announced that Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca PLC at Catalent’s manufacturing facility in Anagni, Italy, and prepare for large scale...
|
|
|
|
| | |
| |
|
|
|
Corning Inc to expand Valor Glass production to accelerate delivery ahead of potential COVID-19 vaccines, treatments
Corning Inc. will receive $204 million in federal funding to expand manufacturing of its Corning Valor Glass packaging in order to expand production and aid the fight against COVID-19....
|
|
|
| |
| |
|
TrialSpark announces launch of Project Covalence, a clinical trial platform to rapidly test drugs and diagnostics for COVID-19
TrialSpark announced the launch of Project Covalence, a turnkey trial platform that enables investigators and sponsors to rapidly launch clinical trials for COVID-19. Project Covalence is a collaboration...
|
|
|
|
| | |
| |
|
|
|
Sanofi invests in vaccine research and production
Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks.
|
|
| |
| | | | |
|